1-11 of 11
Marisa Dolled-Filhart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4213: Molecular biomarker study of programmed death receptor ligand 1 (PD-L1) in Korean patients with lung adenocarcinoma

Xiaoqiao Liu, Jinseon Lee, Soo Jung Lee, Jong Ho Cho, Jong-Mu Sun, Lu Zhang, Yunfei Pei, Lan Chen, Marisa Dolled-Filhart, Kenneth Emancipator, Jared Lunceford, Ronghua Chen, Wei Zhou, Jhingook Kim
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4213.
https://doi.org/10.1158/1538-7445.AM2018-4213
Published: 01 July 2018
View articletitled, Abstract 4213: Molecular biomarker study of programmed death receptor ligand 1 (PD-L1) in Korean patients with lung adenocarcinoma
Journal Articles

Abstract 570: PD-L1 expression in paired non-small cell lung cancer tumor samples

Jhingook Kim, Steffen Filskov Sorensen, Yoon-La Choi, Zhen (Adelle) Wang, Jong-Mu Sun, Hyejoo Choi, Jeanette Baehr Georgsen, Marisa Dolled-Filhart, Kenneth Emancipator, Dianna Y. Wu, Peter Meldgaard, Wei Zhou, Henrik Hager
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 570.
https://doi.org/10.1158/1538-7445.AM2015-570
Published: 01 August 2015
View articletitled, Abstract 570: PD-L1 expression in paired non-small cell lung cancer tumor samples
Journal Articles

Abstract 4303: Programmed death ligand 1 (PD-L1) expression in paired melanoma tumor samples

Torben Steiniche, Allan Vestergaard Danielsen, Zhen (Adelle) Wang, Patricia Switten Nielsen, Lars Bastholt, Henrik Schmidt, Inge Marie Svane, Marisa Dolled-Filhart, Kenneth Emancipator, Dianna Y. Wu, Michael Busch-Sorensen, Wei Zhou
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4303.
https://doi.org/10.1158/1538-7445.AM2015-4303
Published: 01 August 2015
View articletitled, Abstract 4303: Programmed death ligand 1 (PD-L1) expression in paired melanoma tumor samples
Journal Articles

Abstract S1-09: A phase Ib study of pembrolizumab (MK-3475) in patients with advanced triple-negative breast cancer

Rita Nanda, Laura Q Chow, E Claire Dees, Raanan Berger, Shilpa Gupta, Ravit Geva, Lajos Pusztai, Marisa Dolled-Filhart, Kenneth Emancipator, Edward J Gonzalez, Jennifer Houp, Kumudu Pathiraja, Vassiliki Karantza, Robert Iannone, Christine K Gause, Johnathan D Cheng, Laurence Buisseret
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): S1-09.
https://doi.org/10.1158/1538-7445.SABCS14-S1-09
Published: 01 May 2015
View articletitled, Abstract S1-09: A phase Ib study of pembrolizumab (MK-3475) in patients with advanced triple-negative breast cancer
Journal Articles

Abstract CT105: MK-3475 (anti-PD-1 monoclonal antibody) for non-small cell lung cancer (NSCLC): Antitumor activity and association with tumor PD-L1 expression

Leena Gandhi, Ani Balmanoukian, Rina Hui, Omid Hamid, Naiyer A. Rizvi, Natasha Leighl, Matthew Gubens, Jonathan W. Goldman, Gregory M. Lubiniecki, Kenneth Emancipator, Marisa Dolled-Filhart, Jared K. Lunceford, Michelle Niewood, Kevin Gergich, Edward B. Garon
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT105.
https://doi.org/10.1158/1538-7445.AM2014-CT105
Published: 01 October 2014
View articletitled, Abstract CT105: MK-3475 (anti-PD-1 monoclonal antibody) for non-small cell lung cancer (NSCLC): Antitumor activity and association with tumor PD-L1 expression
Journal Articles

Abstract CT104: Antitumor activity of the anti-PD-1 monoclonal antibody MK-3475 in melanoma(MEL): Correlation of tumor PD-L1 expression with outcome

Adil I. Daud, Omid Hamid, Antoni Ribas, F. Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jedd Wolchok, Peter Hersey, Jeffrey S. Weber, Richard Joseph, Tara C. Gangadhar, Roxana S. Dronca, Amita Patnaik, Hassane Zarour, Anthony M. Joshua, Kevin Gergich, Dianna Wu, Jared K. Lunceford, Kenneth Emancipator, Marisa Dolled-Filhart, Nicole Li, Scot Ebbinghaus, S. Peter Kang, Caroline Robert
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT104.
https://doi.org/10.1158/1538-7445.AM2014-CT104
Published: 01 October 2014
View articletitled, Abstract CT104: Antitumor activity of the anti-PD-1 monoclonal antibody MK-3475 in melanoma(MEL): Correlation of tumor PD-L1 expression with outcome
Journal Articles

Quantitative In situ Analysis of β-Catenin Expression in Breast Cancer Shows Decreased Expression Is Associated with Poor Outcome

Marisa Dolled-Filhart, Anthony McCabe, Jennifer Giltnane, Melissa Cregger, Robert L. Camp, David L. Rimm
Journal: Cancer Research
Cancer Res (2006) 66 (10): 5487–5494.
https://doi.org/10.1158/0008-5472.CAN-06-0100
Published: 16 May 2006
View articletitled, Quantitative In situ Analysis of β-Catenin Expression in Breast Cancer Shows Decreased Expression Is Associated with Poor Outcome
Open the PDF for Quantitative In situ Analysis of β-Catenin Expression in Breast Cancer Shows Decreased Expression Is Associated with Poor Outcome in another window
Journal Articles

Protein expression profiling of the HER receptor family using automated quantitative analysis (AQUA) of breast cancer tissue microarrays

Jena M. Giltnane, Marisa Dolled-Filhart, David A. Eberhard, Robert L. Camp, David L. Rimm
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 739.
Published: 01 May 2005
View articletitled, Protein expression profiling of the HER receptor family using automated quantitative analysis (AQUA) of breast cancer tissue microarrays
Journal Articles

Automated Quantitative Analysis of Tissue Microarrays Reveals an Association between High Bcl-2 Expression and Improved Outcome in Melanoma

Kyle A. DiVito, Aaron J. Berger, Robert L. Camp, Marisa Dolled-Filhart, David L. Rimm, Harriet M. Kluger
Journal: Cancer Research
Cancer Res (2004) 64 (23): 8773–8777.
https://doi.org/10.1158/0008-5472.CAN-04-1387
Published: 01 December 2004
View articletitled, Automated Quantitative Analysis of Tissue Microarrays Reveals an Association between High Bcl-2 Expression and Improved Outcome in Melanoma
Open the PDF for Automated Quantitative Analysis of Tissue Microarrays Reveals an Association between High Bcl-2 Expression and Improved Outcome in Melanoma in another window
Journal Articles

Quantitative Analysis of Breast Cancer Tissue Microarrays Shows That Both High and Normal Levels of HER2 Expression Are Associated with Poor Outcome

Robert L. Camp, Marisa Dolled-Filhart, Bonnie L. King, David L. Rimm
Journal: Cancer Research
Cancer Res (2003) 63 (7): 1445–1448.
Published: 01 April 2003
View articletitled, Quantitative Analysis of Breast Cancer Tissue Microarrays Shows That Both High and Normal Levels of HER2 Expression Are Associated with Poor Outcome
Open the PDF for Quantitative Analysis of Breast Cancer Tissue Microarrays Shows That Both High and Normal Levels of HER2 Expression Are Associated with Poor Outcome in another window
Journal Articles

Tissue Microarray Analysis of Hepatocyte Growth Factor/Met Pathway Components Reveals a Role for Met, Matriptase, and Hepatocyte Growth Factor Activator Inhibitor 1 in the Progression of Node-negative Breast Cancer

Jung Y. Kang, Marisa Dolled-Filhart, Idris Tolgay Ocal, Baljit Singh, Chen-Yong Lin, Robert B. Dickson, David L. Rimm, Robert L. Camp
Journal: Cancer Research
Cancer Res (2003) 63 (5): 1101–1105.
Published: 01 March 2003
View articletitled, Tissue Microarray Analysis of Hepatocyte Growth Factor/Met Pathway Components Reveals a Role for Met, Matriptase, and Hepatocyte Growth Factor Activator Inhibitor 1 in the Progression of Node-negative Breast Cancer
Open the PDF for Tissue Microarray Analysis of Hepatocyte Growth Factor/Met Pathway Components Reveals a Role for Met, Matriptase, and Hepatocyte Growth Factor Activator Inhibitor 1 in the Progression of Node-negative Breast Cancer in another window